ADDITIVE NEUROPROTECTIVE EFFECT OF 3-HYDROXYPYRIDINE DERIVATIVES AND HUMAN ERYTHROPOETIN ANALOGUE ON A HEMORRHAGIC STROKE MODEL IN RATS

Author:

Kolesnichenko P. D.1ORCID,Scheblykina O. V.1,Nesterova N. I.2,Scheblykin D. V.1ORCID,Nesterov A. V.1,Pokrovskiy M. V.1ORCID,Zhuchenko M. A.3,Tverskoy A. V.1ORCID,Reznikov K. M.4

Affiliation:

1. Belgorod State National Research University

2. Belgorod State National Research University; Belgorod Bureau of Forensic Medical Examination

3. “PHARMAPARK”

4. Voronezh State Medical University named after N.N. Burdenko

Abstract

The correction of free radical oxidation processes is one of the most promising strategies of neuroprotection in acute cerebrovascular disorders.The aim of the study is an experimental study of the neuroprotective effects of 3-hydroxypyridine and erythropoietin derivatives, as well as their combined use.Materials and methods. The study was performed on 109 male Wistar rats. The neuroprotective effect of the substances was studied on a hemorrhagic stroke model. The study drugs were administered to the animals intraperitoneally. Carbamylated darbepoetin was administered three times in advance at the dose of 100 µg/kg within intervals of 3 days, the last injection took place 1 hour before the operation (the total dose was 300 mg/kg). Etoxidol was administered once 1 hour before the surgery at the dose of 50 mg/kg. The survival rate, behavioral features and the state of the animals on the 1st, 3rd, 7th and 14th days were recorded, and the morphological assessment of the brain was carried out.Results. The investigated substances had a positive effect on both the survival rate of the animals during the first day and on the 14th day. The best survival rates on the 14th day were recorded in the group of a combined use of ethoxydol and carbamylated darbepoetin (75%). Thus, in this group of rats, a faster recovery of neurological disorders was already distinguished from the first day on. By the 7th day, more than 50% of the rats receiving the combination of the studied drugs, had had a slight neurological deficit (up to 3 points on the McGrow scale); by the 14th day there had been only minor changes in the neurological status in the rats of this group. A pronounced neuroprotective effect of the combination of 3-hydroxypyridine and erythropoietin derivatives has been confirmed by a histological examination of brain slices – a more rapid decrease in the size of perifocal edema and microcirculation disorders, less damage to neurons and glial elements, and faster processes of resorption and organization of hemorrhage. A macroscopic examination of the brain sections stained with triphenyltetrazolium chloride of the dying rats, showed that perifocal necrosis had been the main cause of high mortality in the control group after the 3rd day.Conclusion. As a result of the experiment, the nephroprotective effect of the studied derivatives of 3-hydroxypyridine and erythropoietin has been proved. Moreover, the combination of these drugs has shown a greater neuroprotective activity than their isolated use. The additive effect of these drugs was due to their action mechanism resulting from the synergism of various structures and components of the cells.

Publisher

Volgograd State Medical University

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Pharmacy

Reference27 articles.

1. Kesarev OG, Danilenko LM, Pokrovskii MV, Timokhina AS, Khavanskii AV. Study of dose-dependent effect of 2-ethyl-6-methyl-3 hydroxypyridine succinate on the contractile function of isolated rat heat. Research Result in Pharmacology. 2017;3(1):3–9. DOI: 10.18413/2500-235X2017-3-1-3-9.

2. Skvorcova VI, Chazova IE, Stahovskaja LV. [Vtorichnaja profilaktika insul’ta]. M.: PAGRI. 2002: 120p. Russian

3. Karpov SM, Dolgova IN, Vishlova IA. The main issues of topical diagnosis of nervous system diseases. Stavropol. Stavropol State Medical University. 2015:120p.

4. Reznikov KM, Gorbunova NS, Kolesnichenko PD, Tverskoy AV, Kostina DA, Bashkatova DA, Nikitina VA. Search of new pharmaceuticals on the basis of darbepoetin in the treatment of ischemic stroke (review of literature). Research Result: Pharmacology and Clinical Pharmacology. 2017;3(1):125–136. DOI: 10.18413/2500-235X-2017-3-1-125-136

5. Zhu L, Bai X, Wang S, Hu Y, Wang T, Qian L, Jiang L. Recombinant human erythropoietin augments angiogenic responses in a neonatal rat model of cerebral unilateral hypoxia-ischemia. Neonatology. 2014;106(2):143–148. DOI: 10.1159/000362262.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3